Down-regulation of phenobarbital-induced cytochrome P4502B mRNAs and proteins by endotoxin in mice: Independence from nitric oxide production by inducible nitric oxide synthase

Biochemical Pharmacology

Volumn 64, Issue 12, 2002, Pages 1703-1711

  Li Masters, Tong ^a   Morgan, Edward T ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Bacterial endotoxin; Cytochrome P450; Inflammation; Mouse liver; Nitric oxide; Phenobarbital

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; CYTOCHROME P450 2B; CYTOCHROME P450 2B10; CYTOCHROME P450 2B9; CYTOCHROME P450 ISOENZYME; ESCHERICHIA COLI ENDOTOXIN; MESSENGER RNA; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PHENOBARBITAL; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; FEMALE; IN VIVO STUDY; LIVER MICROSOME; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT; STRAIN DIFFERENCE; TIME; WILD TYPE;

ANIMALS; CYTOCHROME P-450 CYP2B1; DOSE-RESPONSE RELATIONSHIP, DRUG; DOWN-REGULATION; DRUG INTERACTIONS; FEMALE; GENE EXPRESSION; GENE SILENCING; LIPOPOLYSACCHARIDES; LIVER; MALE; MICE; MICE, INBRED C57BL; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; PHENOBARBITAL; RATS; RATS, INBRED F344; RNA, MESSENGER;

EID: 0037114459     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(02)01423-5     Document Type: Article

References (27)

1. Morgan E.T. Regulation of cytochromes P450 during inflammation and infection. Drug Metab. Rev. 29:1997;1129-1188.
2. Gorodischer R., Krasner J., McDevitt J.J., Nolan J.P., Yaffe S.J. Hepatic microsomal drug metabolism after administration of endotoxin in rats. Biochem. Pharmacol. 25:1976;351-353.
3. Stanley L.A., Adams D.J., Lindsay R., Meehan R.R., Liao W., Wolf C.R. Potentiation and suppression of mouse liver cytochrome P-450 isozymes during the acute-phase response induced by bacterial endotoxin. Eur. J. Biochem. 174:1988;31-36.
4. Morgan E.T. Suppression of constitutive cytochrome P-450 gene expression in livers of rats undergoing an acute phase response to endotoxin. Mol. Pharmacol. 36:1989;699-707.
5. Shedlofsky S.I., Israel B.C., McClain C.J., Hill D.B., Blouin R.A. Endotoxin administration to humans inhibits hepatic cytochrome P450-mediated metabolism. J. Clin. Invest. 94:1994;2209-2214.
6. Nathan C. Nitric oxide as a secretory product of mammalian cells. FASEB J. 6:1992;3051-3064.
7. Wink D.A., Osawa Y., Darbyshire J.F., Jones C.R., Eshenaur S.C., Nims R.W. Inhibition of cytochromes P450 by nitric oxide and a nitric oxide-releasing agent. Arch. Biochem. Biophys. 300:1993;115-123.
8. Minamiyama Y., Takemura S., Imaoka S., Funae Y., Tanimoto Y., Inoue M. Irreversible inhibition of cytochrome P450 by nitric oxide. J. Pharmacol. Exp. Ther. 283:1997;1479-1485.
9. Roberts E.S., Lin H., Crowley J.R., Vuletich J.L., Osawa Y., Hollenberg P.F. Peroxynitrite-mediated nitration of tyrosine and inactivation of the catalytic activity of cytochrome P450 2B1. Chem. Res. Toxicol. 11:1998;1067-1074.
10. Khatsenko O., Kikkawa Y. Nitric oxide differentially affects constitutive cytochrome P450 isoforms in rat liver. J. Pharmacol. Exp. Ther. 280:1997;1463-1470.
11. Osawa Y., Davila J.C., Nakatsuka M., Meyer C.A., Darbyshire J.F. Inhibition of P450 cytochromes by reactive intermediates. Drug Metab. Rev. 27:1995;61-72.
12. Stadler J., Trockfeld J., Schmalix W.A., Brill T., Siewert J.R., Greim H., Doehmer J. Inhibition of cytochromes P4501A by nitric oxide. Proc. Natl. Acad. Sci. U.S.A. 91:1994;3559-3563.
13. Donato M.T., Guillén M.I., Jover R., Castell J.V., Gómez-Lechón M.J. Nitric oxide-mediated inhibition of cytochrome P450 by interferon-γ in human hepatocytes. J. Pharmacol. Exp. Ther. 281:1997;484-490.
14. Sewer M.B., Morgan E.T. Nitric oxide-independent suppression of P450 2C11 expression by interleukin-1β and endotoxin in primary rat hepatocytes. Biochem. Pharmacol. 54:1997;729-737.
15. Sewer M.B., Morgan E.T. Down-regulation of the expression of three major rat liver cytochrome P450S by endotoxin in vivo occurs independently of nitric oxide production. J. Pharmacol. Exp. Ther. 287:1998;352-358.
16. Sewer M.B., Barclay T.B., Morgan E.T. Down-regulation of cytochrome P450 mRNAs and proteins in mice lacking a functional NOS2 gene. Mol. Pharmacol. 54:1998;273-279.
17. Carlson T.J., Billings R.E. Role of nitric oxide in the cytokine-mediated regulation of cytochrome P-450. Mol. Pharmacol. 49:1996;796-801.
18. Khatsenko O.G., Boobis A.R., Gross S.S. Evidence for nitric oxide participation in down-regulation of CYP2B1/2 gene expression at the pretranslational level. Toxicol. Lett. 90:1997;207-216.
19. Ferrari L., Peng N., Halpert J.R., Morgan E.T. Role of nitric oxide in down-regulation of CYP2B1 protein, but not RNA, in primary cultures of rat hepatocytes. Mol. Pharmacol. 60:2001;209-216.
20. Laubach V.E., Shesely E.G., Smithies O., Sherman P.A. Mice lacking inducible nitric oxide synthase are not resistant to lipopolysaccharide-induced death. Proc. Natl. Acad. Sci. U.S.A. 92:1995;10688-10692.
21. Li-Masters T., Morgan E.T. Effects of bacterial lipopolysaccharide on phenobarbital-induced CYP2B expression in mice. Drug Metab. Dispos. 29:2001;252-257.
22. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:1987;156-159.
23. Morgan E.T., Thomas K.B., Swanson R., Vales T., Hwang J., Wright K. Selective suppression of cytochrome P-450 gene expression by interleukins 1 and 6 in rat liver. Biochim. Biophys. Acta. 1219:1994;475-483.
24. Haugen D.A., Coon M.J. Properties of electrophoretically homogeneous phenobarbital-inducible and β-naphthoflavone-inducible forms of liver microsomal cytochrome P-450. J. Biol. Chem. 251:1976;7929-7939.
25. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193:1951;265-275.
26. Chen L., Waxman D.J. Intratumoral activation and enhanced chemotherapeutic effect of oxazaphosphorines following cytochrome P-450 gene transfer: development of a combined chemotherapy/cancer gene therapy strategy. Cancer Res. 55:1995;581-589.
27. Ekins S., Wrighton S.A. The role of CYP2B6 in human xenobiotic metabolism. Drug Metab. Rev. 31:1999;719-754.